- Report
- January 2024
- 80 Pages
Global
From €5661EUR$5,950USD£4,847GBP
- Report
- January 2024
- 200 Pages
Global
From €4757EUR$5,000USD£4,073GBP
- Report
- April 2024
- 137 Pages
Global
From €3710EUR$3,899USD£3,176GBP
- Report
- June 2023
- 113 Pages
Global
From €4662EUR$4,900USD£3,992GBP
- Report
- January 2024
- 140 Pages
Global
From €4044EUR$4,250USD£3,462GBP
- Report
- July 2023
- 321 Pages
Global
From €4282EUR$4,500USD£3,666GBP
- Report
- February 2024
- 108 Pages
Global
From €4519EUR$4,750USD£3,870GBP
- Clinical Trials
- April 2024
- 107 Pages
Global
From €1903EUR$2,000USD£1,629GBP
- Report
- March 2024
- 180 Pages
Global
From €3210EUR$3,374USD£2,749GBP
€3567EUR$3,749USD£3,054GBP
- Report
- September 2023
- 180 Pages
Global
From €5661EUR$5,950USD£4,847GBP
- Drug Pipelines
- April 2024
- 75 Pages
Global
From €1903EUR$2,000USD£1,629GBP
- Report
- July 2019
- 151 Pages
Global
From €1308EUR$1,375USD£1,120GBP
€2617EUR$2,750USD£2,240GBP
- Report
- July 2022
- 298 Pages
Global
From €3330EUR$3,500USD£2,851GBP
- Report
- May 2024
- 132 Pages
From €6184EUR$6,499USD£5,295GBP
- Report
- September 2020
- 120 Pages
Europe
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- September 2020
- 117 Pages
Asia Pacific
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- September 2020
- 117 Pages
North America
From €1998EUR$2,100USD£1,711GBP
€2854EUR$3,000USD£2,444GBP
- Report
- January 2022
- 200 Pages
Global
From €7136EUR$7,500USD£6,110GBP
- Report
- January 2019
Global
From €4282EUR$4,500USD£3,666GBP
- Report
- November 2022
- 120 Pages
Global
From €2379EUR$2,500USD£2,037GBP
The Herpes Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases. Herpes drugs are used to treat the herpes simplex virus (HSV) and its associated conditions, such as genital herpes, cold sores, and shingles. These drugs can be administered orally, topically, or intravenously, depending on the severity of the infection. Commonly prescribed herpes drugs include acyclovir, valacyclovir, and famciclovir.
Herpes drugs are typically prescribed for short-term use, as the virus is incurable. However, these drugs can help reduce the severity and duration of symptoms, as well as reduce the risk of transmission. As such, they are an important part of managing the virus.
Some companies in the Herpes Drug market include GlaxoSmithKline, Merck, Pfizer, and Novartis. These companies produce a variety of herpes drugs, including acyclovir, valacyclovir, and famciclovir. Show Less Read more